Lineage Cell Therapeutics (LCTX) News Today $1.03 +0.01 (+0.98%) Closing price 07/11/2025 04:10 PM EasternExtended Trading$1.02 -0.01 (-0.49%) As of 07/11/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock LCTX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Lineage Cell Therapeutics shareholders approve board slate and equity plan amendment - Investing.comJuly 4, 2025 | investing.comLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Shares Acquired by Defender Capital LLC.July 2, 2025 | marketbeat.comLCTX Lineage Cell Therapeutics, Inc. - Seeking AlphaJune 27, 2025 | seekingalpha.comLineage Cell Therapeutics (AMEX:LCTX) Stock, Short Interest ReportJune 23, 2025 | benzinga.comLineage Cell Therapeutics (AMEX:LCTX) Stock, Insider Trading ActivityJune 23, 2025 | benzinga.comLineage Cell Therapeutics Earnings Estimates, EPS & Revenue | AMEX:LCTX | BenzingaJune 23, 2025 | benzinga.comD. Boral Capital Reaffirms "Buy" Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)June 23, 2025 | marketbeat.comLineage Cell Therapeutics (NYSEAMERICAN:LCTX) Earns Buy Rating from HC WainwrightJune 23, 2025 | marketbeat.comOpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025June 23, 2025 | businesswire.comLineage Cell Therapeutics appoints new auditorJune 11, 2025 | investing.comLineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor SymposiumJune 5, 2025 | finance.yahoo.comB. Riley Predicts Lineage Cell Therapeutics FY2029 EarningsMay 27, 2025 | marketbeat.comLineage Cell Therapeutics at H.C. Wainwright: Strategic Insights on OpRegenMay 21, 2025 | investing.comJacobs Levy Equity Management Inc. Purchases Shares of 1,033,763 Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)May 20, 2025 | marketbeat.comComerica Bank Boosts Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)May 18, 2025 | marketbeat.comLineage Cell Therapeutics’ Earnings Call Highlights Progress and ChallengesMay 15, 2025 | tipranks.comLineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYCMay 14, 2025 | businesswire.comLineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comLineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13, 2025 | businesswire.comExamining the Future: Lineage Cell Therapeutics's Earnings OutlookMay 12, 2025 | benzinga.comRG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025May 12, 2025 | businesswire.comDAFNA Capital Management LLC Raises Stock Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)May 10, 2025 | marketbeat.comAlyeska Investment Group L.P. Takes Position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)May 9, 2025 | marketbeat.comLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Shares Purchased by Raffles Associates LPMay 3, 2025 | marketbeat.comLineage Cell Therapeutics (LCTX) to Release Earnings on ThursdayMay 3, 2025 | marketbeat.comLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Shares Bought by Renaissance Technologies LLCMay 2, 2025 | marketbeat.comLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Sees Large Increase in Short InterestApril 23, 2025 | marketbeat.comLineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor SymposiumApril 22, 2025 | businesswire.comLineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)April 21, 2025 | finance.yahoo.comLineage Cell Therapeutics (NYSEAMERICAN:LCTX) Shares Down 7.4% - Here's What HappenedApril 10, 2025 | marketbeat.comMaxim Group Reaffirms Their Buy Rating on Lineage Therap (LCTX)April 5, 2025 | markets.businessinsider.comB. Riley Forecasts Lineage Cell Therapeutics Q1 EarningsMarch 17, 2025 | marketbeat.comB. Riley Issues Pessimistic Forecast for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Stock PriceMarch 15, 2025 | marketbeat.comHC Wainwright Weighs in on Lineage Cell Therapeutics Q1 EarningsMarch 14, 2025 | marketbeat.comBeyond The Numbers: 7 Analysts Discuss Lineage Cell Therapeutics StockMarch 13, 2025 | nasdaq.comLineage Cell Therapeutics (NYSEAMERICAN:LCTX) Receives Buy Rating from HC WainwrightMarch 12, 2025 | marketbeat.comD. Boral Capital Reaffirms Buy Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)March 12, 2025 | marketbeat.comLineage Cell Therapeutics Faces Uncertainty Amid New U.S. Administration’s PoliciesMarch 12, 2025 | tipranks.comLineage Cell Therapeutics’ Earnings Call: Progress Amid ChallengesMarch 11, 2025 | tipranks.comLineage Cell Therapeutics, Inc. (AMEX:LCTX) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | insidermonkey.comLineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call TranscriptMarch 10, 2025 | seekingalpha.comLineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateMarch 10, 2025 | businesswire.comLineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) Short Interest UpdateFebruary 15, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)February 11, 2025 | marketbeat.comLineage Initiates Clinical Study of OPC1 for Spinal Cord InjuryFebruary 11, 2025 | finance.yahoo.comLineage Cell Therapeutics initiates study of OPC1 for spinal injuryFebruary 11, 2025 | markets.businessinsider.comD. Boral Capital Has Lowered Expectations for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Stock PriceFebruary 11, 2025 | marketbeat.comLineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences ConferenceFebruary 4, 2025 | finance.yahoo.comInsiders Are Scooping Up These 5 Stocks NowFebruary 2, 2025 | 247wallst.comPromising Advancements in Cell Therapy: Lineage Cell Therapeutics Receives Buy Rating from Joseph PantginisJanuary 31, 2025 | markets.businessinsider.com Get Lineage Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address LCTX Media Mentions By Week LCTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LCTX News Sentiment▼0.001.01▲Average Medical News Sentiment LCTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LCTX Articles This Week▼01▲LCTX Articles Average Week Get Lineage Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LCTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Anavex Life Sciences News Oric Pharmaceuticals News LENZ Therapeutics News Zymeworks News Arcus Biosciences News Avadel Pharmaceuticals News Cogent Biosciences News Oculis News Basilea Pharmaceutica News Chimerix News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:LCTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
